Top 50 Health Care VC Funds & Investors in Europe (October 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Bpifrance
VC Fund
|
211 | France, United States, Switzerland | Seed, Venture - Series Unknown, Series A | Software, Health Care, Biotechnology | $752k–$34M |
|
SOSV
VC Fund
|
207 | United States, China, Canada | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | $50k–$5M |
|
HTGF (High-Tech Gruenderfonds)
VC Fund
|
142 | Germany, Switzerland, United States | Seed, Series A, Pre-Seed | Software, Biotechnology, Information Technology | $790k–$31M |
|
Enterprise Ireland
VC Fund
|
115 | Ireland, United States, United Kingdom | Seed, Venture - Series Unknown, Grant | Software, Health Care, Information Technology | $26k–$8.3M |
|
SFC Capital
VC Fund
|
109 | United Kingdom, United States, Ireland | Seed, Pre-Seed, Venture - Series Unknown | Software, Artificial Intelligence, Information Technology | $123k–$2.5M |
|
Almi Invest
VC Fund
|
91 | Sweden, Norway, United States | Venture - Series Unknown, Seed | Software, Health Care, Information Technology | $226k–$3.5M |
|
Sofinnova Partners
VC Fund
|
80 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $7M–$105M |
|
Calm/Storm VC
VC Fund
|
80 | United Kingdom, Germany, Austria | Seed, Pre-Seed, Series A | Health Care, Wellness, Software | $538k–$18M |
|
Parkwalk Advisors
VC Fund
|
78 | United Kingdom, United States, Philippines | Seed, Series A, Series B | Biotechnology, Health Care, Software | $991k–$44M |
|
Scottish Enterprise
VC Fund
|
77 | United Kingdom, United States, Switzerland | Grant, Seed, Venture - Series Unknown | Biotechnology, Software, Health Care | $119k–$8.4M |
|
Antler
VC Fund
|
72 | United States, Singapore, Australia | Pre-Seed, Seed, Series A | Software, Artificial Intelligence, Information Technology | $100k–$29M |
|
UK Innovation & Science Seed Fund
VC Fund
|
71 | United Kingdom, United States | Seed, Venture - Series Unknown | Biotechnology, Health Care, Medical | $582k–$6.7M |
|
Kurma Partners
VC Fund
|
70 | France, Switzerland, The Netherlands | Series A, Seed, Series B | Health Care, Biotechnology, Pharmaceutical | $2.8M–$98M |
|
Hiventures
VC Fund
|
67 | Hungary, United States, United Kingdom | Pre-Seed, Seed, Series A | Software, Information Technology, Manufacturing | $18k–$2.9M |
|
Business Growth Fund
VC Fund
|
67 | United Kingdom, Ireland, United States | Venture - Series Unknown, Private Equity, Series A | Software, Manufacturing, Information Technology | $3.4M–$22M |
|
Oxford Science Enterprises
VC Fund
|
63 | United Kingdom, United States, Finland | Seed, Series A, Series B | Health Care, Biotechnology, Medical | $1.3M–$168M |
|
Novo Holdings
VC Fund
|
62 | United States, Denmark, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $9.5M–$135M |
|
Future Planet Capital
VC Fund
|
61 | United Kingdom, United States, Singapore | Seed, Convertible Note | Biotechnology, Health Care, Software | $670k–$5.1M |
|
Portugal Ventures
VC Fund
|
56 | Portugal, United States, United Kingdom | Seed, Venture - Series Unknown, Pre-Seed | Software, Information Technology, Health Care | $107k–$3.6M |
|
Development Bank of Wales
VC Fund
|
56 | United Kingdom, Australia, United States | Seed, Debt Financing, Venture - Series Unknown | Software, Health Care, Manufacturing | $19k–$5.5M |
|
Speedinvest
VC Fund
|
53 | United Kingdom, Germany, Austria | Seed, Series A, Pre-Seed | Software, FinTech, Artificial Intelligence | $411k–$32M |
|
Seventure Partners
VC Fund
|
51 | France, United States, Germany | Series A, Series B, Seed | Biotechnology, Software, Health Care | $1.1M–$63M |
|
Scottish Investment Bank
VC Fund
|
50 | United Kingdom, United States, France | Venture - Series Unknown, Seed, Series A | Software, Biotechnology, Health Care | $199k–$7.5M |
|
Northstar Ventures
VC Fund
|
50 | United Kingdom, United States, Indonesia | Seed, Venture - Series Unknown, Series A | Software, Health Care, Information Technology | $46k–$10M |
|
Inveready
VC Fund
|
50 | Spain, United States, France | Seed, Venture - Series Unknown, Debt Financing | Software, Biotechnology, Health Care | $400k–$6.5M |
|
Deepbridge Capital
VC Fund
|
49 | United Kingdom, Spain, Australia | Seed, Venture - Series Unknown, Series A | Health Care, Biotechnology, Medical | $142k–$15M |
|
IBB Ventures
VC Fund
|
47 | Germany, United States, United Kingdom | Seed, Series A, Pre-Seed | Software, Health Care, SaaS | $468k–$11M |
|
Oxford Technology Management
VC Fund
|
47 | United Kingdom, United States | Seed, Series A | Biotechnology, Health Care, Software | $33k–$8.5M |
|
Idinvest Partners
VC Fund
|
46 | France, United States, Germany | Series A, Series B, Venture - Series Unknown | Software, Health Care, Biotechnology | $3.4M–$66M |
|
Atlantic
VC Fund
|
46 | Germany, Switzerland, United States | Seed, Pre-Seed, Series A | Software, Health Care, Artificial Intelligence | $850k–$30M |
|
Mercia Fund Managers
VC Fund
|
45 | United Kingdom, United States, Hungary | Seed, Venture - Series Unknown, Series A | Software, Health Care, Biotechnology | $250k–$14M |
|
AlbionVC
VC Fund
|
43 | United Kingdom, United States, France | Series A, Seed, Series B | Software, Artificial Intelligence, Health Care | $2.4M–$45M |
|
Entrepreneurs First
VC Fund
|
43 | United Kingdom, Singapore, United States | Seed, Pre-Seed, Series A | Artificial Intelligence, Software, Machine Learning | $54k–$41M |
|
Octopus Ventures
VC Fund
|
43 | United Kingdom, United States, Germany | Series A, Seed, Series B | Software, Artificial Intelligence, Health Care | $2.1M–$43M |
|
Innovate UK
VC Fund
|
42 | United Kingdom, United States, Ireland | Grant, Pre-Seed, Seed | Health Care, Biotechnology, Software | $58k–$3.5M |
|
Bayern Kapital
VC Fund
|
42 | Germany, United States, United Kingdom | Seed, Series A, Series B | Software, Health Care, SaaS | $1.2M–$132M |
|
SOSV HAX
VC Fund
|
41 | United States, Canada, China | Seed, Convertible Note, Pre-Seed | Robotics, Manufacturing, Health Care | $25k–$4.7M |
|
SyndicateRoom
VC Fund
|
40 | United Kingdom, United States, India | Seed, Equity Crowdfunding, Pre-Seed | Health Care, Software, Medical | $390k–$2.7M |
|
CDP Venture Capital
VC Fund
|
39 | Italy, United States, Switzerland | Seed, Series A, Venture - Series Unknown | Software, Artificial Intelligence, Health Care | $483k–$23M |
|
Seedcamp
VC Fund
|
39 | United Kingdom, United States, France | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, Information Technology | $587k–$30M |
|
IP Group
VC Fund
|
37 | United Kingdom, United States, Australia | Seed, Series A, Series B | Biotechnology, Health Care, Information Technology | $208k–$68M |
|
Elaia
VC Fund
|
37 | France, United States, Spain | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $1.1M–$50M |
|
Kima Ventures
VC Fund
|
37 | France, United States, United Kingdom | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, SaaS | $515k–$16M |
|
Karista
VC Fund
|
36 | France, United States, Finland | Seed, Series A, Series B | Software, Biotechnology, Health Care | $768k–$33M |
|
EISMEA
VC Fund
|
36 | Spain, Italy, United Kingdom | Grant, Venture - Series Unknown, Seed | Manufacturing, Software, Biotechnology | $53k–$2.6M |
|
ENISA
VC Fund
|
35 | Spain, United States, France | Debt Financing, Seed, Pre-Seed | Software, Health Care, Artificial Intelligence | $68k–$1.6M |
|
Meusinvest (Noshaq)
VC Fund
|
35 | Belgium, France, Germany | Series A, Seed, Venture - Series Unknown | Biotechnology, Health Care, Medical | $137k–$16M |
|
European Investment Bank
VC Fund
|
35 | France, Germany, Italy | Debt Financing, Post-IPO Debt, Venture - Series Unknown | Energy, Biotechnology, Health Care | $8.7M–$587M |
|
GO CAPITAL
VC Fund
|
34 | France, Canada, Israel | Seed, Venture - Series Unknown, Series A | Software, Biotechnology, Health Care | $549k–$13M |
|
Foresight Group
VC Fund
|
34 | United Kingdom, United States, Ireland | Venture - Series Unknown, Private Equity, Seed | Software, Information Technology, Manufacturing | $648k–$8.3M |
| Access all 50 VC funds in Europe Health Care startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: France, United States, Switzerland
Investor stats
- Total investments: 1723
- Round size: Seed $752k–$6.1M; Series A $2.6M–$34M; Venture - Series Unknown $1.1M–$32M
- Lead/follow: 27% lead, 73% follow
- Last fund: Likely actively investing — fresh fund, raised $27M in 2025
Portfolio highlights
- Melvan — Melvan develops, finances, builds and operates solar and wind installations, combined, where relevant, with storage facilities.
- WAAT — WAAT operates fast charging stations for electric and rechargeable hybrid vehicles. Its services are aimed at all private sector market segments, including condominiums, lessees, tertiary, and real estate development. The company was founded in 2018 and is based in Paris with sales offices in Malakoff and Bagneux (92).
- Nepsis — AI-powered software and debt advisory for renewable energy developers. Modern financing solutions for small & medium renewable projects.
SOSV offers pre-seed capital and follow-on financial support to startups focusing on deep technology and scientific innovation. Founders utilize purpose-built laboratory facilities and engineering spaces to accelerate product development and testing. The firm facilitates connections between entrepreneurs and a network of investors through structured matchmaking events and technology summits.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, China, Canada
Investor stats
- Total investments: 3729
- Round size: Seed $150k–$5M; Pre-Seed $50k–$1.6M; Convertible Note $50k–$3.6M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely still investing — raised $306M in 2023
Portfolio highlights
- Halla — Halla Intelligence is a digital solution that leverages over 100 billion shopper and product data points to recommend and promote what grocery items.
- Simply Good Jars — Simply Good Jars is a B-Corp company that delivers healthy meals in reusable + returnable packaging through use of smart refrigerated kiosks placed in offices, transit centers, universities and health-systems. Driven by purpose to change that way people think about consumption, SGJ introduces sustainable business practices into their everydayoperations with a zero-waste goal. For every jar returned back to the company for reuse, they will help feed someone in need and ensure that no packaging materials end up in landfills.
- Verdex Technologies — Verdex Technologies is an advanced materials platform technology that uses nanofibers to disrupt industries. Verdex doesn't just compete, it innovates and disrupts.
High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in various sectors.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 781
- Round size: Seed $790k–$6.9M; Pre-Seed $841k–$2.8M; Series A $3M–$31M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — raised $515M in 2022
Portfolio highlights
- Selfapy — Selfapy offers a therapy support tool that helps recognize negative patterns of thought and train new behavior. Selfapy is your guided, self-help online course against depression with a personal psychologist as a companion.
- Smartblue — Smartblue develops and runs software and processes to monitor and optimize zero emission energy systems. As a hardware independent specialist Smartblue delivers a software service for the maintenance, life-cycle management, production forecasting and remote control of photovoltaic and energy storage systems all together in one centralized “SmartControl” Operations and Control Center web application. We help our customers drive down overall operational cost through automation, smart failure detection and big data analysis on imminent defects.
- OMEICOS Therapeutics — OMEICOS Therapeutics is developing a novel, first-in-class, small molecule utilizing a new Mode of Action. OMEICOS' novel therapeutic strategy is based upon the discovery of natural metabolites of omega-3 fatty acids that mediate a strong anti-arrhythmic effect. In contrast to all other anti-arrhythmic drugs, OMEICOS' substances activatean endogenous cardio-protective signaling pathway that not only stabilizes the heart rhythm but shall provide curative effects to the diseased organ by preventing its electrical and structural remodeling.
Enterprise Ireland is the government agency responsible for the development and funding of the indigenous business sector. Their mission is to accelerate the development of companies to achieve strong positions in global markets resulting in increased national and regional prosperity. It was founded in 1998 and headquartered in Dublin, Ireland.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Venture - Series Unknown, Grant
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 894
- Round size: Seed $394k–$3.2M; Grant $26k–$5.5M; Venture - Series Unknown $560k–$8.3M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — raised $1.2M in 2021
Portfolio highlights
- Foodcloud — We connect businesses that have surplus food with Charities and Community Groups that need it.
- Amethyst Care — Amethyst Care is a startup that creates an AI-powered voice assistant for those with mobility difficulties.
- Full Health Medical — Full Health Medical patient empowerment tools that improve prevention healthcare are part of the healthcare ecosystem. FHM provides reliable digital innovation, designed by healthcare professionals that are keen to help patients live a healthy life, in response to a national scarcity of healthcare providers, the development of chronic disease, anda lack of transparency at the patient level. People provide lifetime access to preventive care healthcare across screening, diagnostics, education, treatment, and a record of their journey driven technology provides lifetime access to preventative healthcare custom designed at every step screening, diagnostics, education, and action plans that motivate individuals to address risks before they develop health problems.
Discover the UK's leading SEIS Fund, offering tax-efficient investments in innovative startups. Join thousands of savvy investors and raise capital for your business with SFC Capital.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 786
- Round size: Seed $123k–$2M; Pre-Seed $170k–$858k; Venture - Series Unknown $201k–$2.5M
- Lead/follow: 36% lead, 64% follow
- Last fund: May invest from a new fund soon — raised $1.9M in 2019
Portfolio highlights
- Obsero — Obsero is an AI search intelligence platform and consultancy designed for marketing and communications teams. The platform tracks, measures, and optimizes how brands surface, get cited, and are recommended across Large Language Models (LLMs) and AI search assistants.
- SolarSub — SolarSub is an environmental firm that offers floating solar cooling system.
- NEARHUMAN — Nearhuman develops intelligent safety systems for micromobility and other physical-world devices. The company focuses on edge AI and computer vision that run directly on vehicles such as e-scooters and e-bikes to detect hazards, monitor pedestrian proximity, and support real-time decision making. Its flagship product, Scootrr, is an AI-powered safety platform that enables on-device perception, automatic deceleration, and safety analytics without reliance on cloud connectivity. Nearhuman designs its technology to integrate with existing shared micromobility fleets, collaborating with operators, vehicle manufacturers, and research partners. The company also provides dashboards and tools that turn on-vehicle events into route-level safety intelligence for stakeholders such as fleet operators and city authorities. Its work spans hardware vision kits, embedded firmware, perception models, and supporting software for deployment and monitoring.
Almi Invest is Sweden’s most active early-stage venture capital firm, investing in scalable startups across Sustainability, Industry, Tech, and Life Science. We invest from pre-seed to Series A, always co-investing with independent private investors to accelerate innovation and long-term success. Our portfolio spans sustainable solutions, industrial innovation, deep tech, SaaS, and life science, supporting startups that drive economic and environmental progress. With €430 million under management and over 1,000 investments since 2009, we have backed leading companies like MIPS, Tobii, and Neo4j, with notable exits to Google, Apple, Microsoft, and Qlik. Beyond capital, we offer engaged ownership, providing strategic guidance, active board participation, and access to an extensive investor network. Almi Invest is part of the Almi Group and is funded by the European Regional Development Fund, Almi AB, and regional partners.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Venture - Series Unknown, Seed
- Geography: Sweden, Norway, United States
Investor stats
- Total investments: 552
- Round size: Seed $226k–$2.2M; Venture - Series Unknown $326k–$3.5M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — raised $64M in 2024
Portfolio highlights
- FirstQFM — FirstQFM is a Stockholm-based quantum technology company building proprietary foundation models for quantum computing.
- Ambidex AB — helps food retailers create new revenue streams on their refrigeration systems by stabilizing the electricity grid.
- Indevex AB — Indevex is a science-based and privately owned biotech company from Sweden. A natural and reliable partner, providing evidence based natural nutrition concepts based on the patented NGC™ Formula.
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 353
- Round size: Series A $7M–$70M; Series B $10M–$105M; Series C $12M–$100M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely actively investing — fresh fund, raised $755M in 2025
Portfolio highlights
- Odoo — From ERP to CRM, eCommerce and CMS. Download Odoo or use it in the cloud. Grow Your Business.
- HighLife — HighLife is driven by a mission to deliver innovative treatment options to patients suffering from heart valve diseases.
- EnginZyme — Enzymatic chemistry for cleaner ingredients in personal care, food and pharma. Enginzyme's patented EziG platform makes enzymes work at industrial scale.
Calm/Storm is an exclusive founder network and venture capital firm. We invest in purpose driven founders changing our life & health for the better. Headquartered in Vienna, Austria we invest in early-stage companies all over Europe and the US. We focus on the pre-seed and seed stages but also invest up to Series A.
Show more...Investment focus
- Industry: Health Care, Wellness, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, Germany, Austria
Investor stats
- Total investments: 144
- Round size: Seed $1.3M–$6.3M; Pre-Seed $538k–$2.6M; Series A $7.6M–$18M
- Lead/follow: 8% lead, 92% follow
- Last fund: Likely still investing — raised $25M in 2023
Portfolio highlights
- PROPCORN AI — At PROPCORN, our goal is to harness the power of AI to automatically unlock the full real estate building potential of our customers, enabling them to make faster and more accurate decisions in real-time.
- aeon.life — Preventive healthcare platform that equips people with personalized insights and expert guidance for proactive whole-body health
- Health Force — Health Force develops AI agents that automate administrative and operational workflows for hospitals and clinics. The company focuses on back-office tasks such as scheduling, billing, procurement, and insurance verification. Its AI agents integrate with existing hospital systems to handle repetitive digital work and reduce manual data entry. Health Force offers its agents on a subscription basis, allowing healthcare providers to adopt automation without major software changes. The service includes an AI readiness assessment, implementation support, and continuous optimization based on observed performance. By shifting routine logistics to AI, Health Force enables healthcare staff to spend more time on direct patient-related activities.
Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009, anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth. Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Philippines
Investor stats
- Total investments: 338
- Round size: Seed $991k–$4.9M; Series A $1.6M–$14M; Series B $1.8M–$44M
- Lead/follow: 27% lead, 73% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- K3 Metrology — K3 Metrology is a specialist metrology company commercialising laser‑based 3D coordinate measurement technology developed at the National Physical Laboratory. The company’s platform is designed to provide high‑accuracy, uncertainty‑aware dimensional data in large‑volume industrial environments, supporting inspection and assembly processes inadvanced manufacturing. Its systems integrate into production workflows where traceable measurements are required across complex geometries and large structures. The technology is applied in sectors such as aerospace, defence, and nuclear, where dimensional integrity and process control are critical.
- MoA Technology — We harness the principles of natural selection to accelerate discovery for better, safer herbicides so farmers can continue to feed the world.
- Quantum Motion — Quantum Motion delivers scalable silicon-based quantum computing using standard semiconductor manufacturing technology.
Scotland's business advice, support and funding agency. Explore our products and services to find the right support for your business and apply online today.
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Grant, Seed, Venture - Series Unknown
- Geography: United Kingdom, United States, Switzerland
Investor stats
- Total investments: 403
- Round size: Seed $387k–$4.3M; Grant $119k–$4.8M; Venture - Series Unknown $681k–$8.4M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- CSignum — Revolutionising underwater communications with electromagnetic technology for seamless data integration between surface & submerged devices.
- GLORIAH — Nurse founded, natural intimate hydration oils and gels for menopause.
- SolarSub — SolarSub is an environmental firm that offers floating solar cooling system.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: United States, Singapore, Australia
Investor stats
- Total investments: 2387
- Round size: Seed $158k–$4.6M; Pre-Seed $100k–$600k; Series A $4.1M–$29M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely actively investing — fresh fund, raised $7.5M in 2026
Portfolio highlights
- iiba — Iiba is a geospatial platform that specializes in providing location information related to child-rearing.
- Obud — Obud is a wellness reservation systems that is designed for holistic health and lifestyle management purposes. The company's systems offer a comprehensive suite of tools for booking wellness activities, managing schedules, and accessing curated wellness programs, enabling wellness centers to streamline their operations, enhance userengagement, and promote a balanced and healthy lifestyle.
- Plouton AI —
UKI2S, formally the Rainbow Seed Fund, is an investment fund backed by the government, providing seed funding to science & technology start-ups and SMEs
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Venture - Series Unknown
- Geography: United Kingdom, United States
Investor stats
- Total investments: 151
- Round size: Seed $582k–$5.9M; Venture - Series Unknown $1M–$6.7M
- Lead/follow: 32% lead, 68% follow
- Last fund: May invest from a new fund soon — last raise in 2014
Portfolio highlights
- Zentraxa — NATURE ENGINEERED FOR PURPOSE Through millions of years of evolution, nature has found solutions to the most difficult problems. Inspired by the diversity of nature, we precision engineer bespoke biomaterials to meet the toughest challenges across
- StandardX — StandardX is a deep-tech company building the isotope refinery powered by a scalable, compact particle accelerator platform.
- SILVIA BIO — SilVia Bio develops technologies to analyze and optimize mammalian cell factories used in biomanufacturing. The company focuses on identifying critical parameters that limit bioproduction yield and product quality in cell systems such as CHO and HEK cells. Its platform provides cell profiling services that generate interpretable data on manufacturing-relevant bottlenecks. Based on these insights, SilVia Bio designs and supplies precision media additives formulated to address specific rate-limiting cellular processes. The offerings are intended for biopharmaceutical and biomanufacturing teams seeking to improve titre, cell performance, and consistency in production processes. SilVia Bio also collaborates with industrial partners to apply its platform within real manufacturing environments.
Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovations in Europe, particularly through links with many institutes. research and prestigious hospitals.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Pharmaceutical
- Stage:Series A, Seed, Series B
- Geography: France, Switzerland, The Netherlands
Investor stats
- Total investments: 146
- Round size: Seed $2.8M–$14M; Series A $3.9M–$98M; Series B $12M–$72M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely still investing — raised $236M in 2024
Portfolio highlights
- RougeTx — RougeTx is a Netherlands-based biotech developing first-in-class small-molecule therapies for vascular diseases caused by pericyte dysfunction. Its lead candidate, RTX-001, targets hereditary haemorrhagic telangiectasia (HHT), an inherited disorder involving fragile blood vessels and recurrent bleeding.
- AM Pharma — AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derivedpeptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
- Nuclidium — NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics.
As one of the largest and most active venture capital fund partners in Central and Eastern Europe our mission is to create new ways of equity funding for innovative small and medium-sized enterprises with high growth potential as well as more traditional businesses for the purpose of establishing a sustainable and competitive SME and enterpriseecosystem both in Hungary and in the region
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Pre-Seed, Seed, Series A
- Geography: Hungary, United States, United Kingdom
Investor stats
- Total investments: 708
- Round size: Seed $118k–$935k; Pre-Seed $18k–$138k; Series A $163k–$2.9M
- Lead/follow: 7% lead, 93% follow
- Last fund: May invest from a new fund soon — raised $493M in 2020
Portfolio highlights
- iBar Experience Kft. — iBar provides an AI inventory app that integrates into restaurant management software. They offer products and services for pizzerias, bars, discos, hotels, and restaurants.
- SURVIOT Monitoring Kft. — SURVIOT equips bridges, tunnels and buildings with automated sensors and software, giving engineers real-time, reliable data on structural health.
- Linkio - Ecommerce Integration Portal — Integrate wholesalers into your online store easier then ever
BGF is the most active equity investor in the UK and Ireland, providing long-term, minority investment to growing companies.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Venture - Series Unknown, Private Equity, Series A
- Geography: United Kingdom, Ireland, United States
Investor stats
- Total investments: 608
- Round size: Series A $4.1M–$21M; Private Equity $6.4M–$22M; Venture - Series Unknown $3.4M–$16M
- Lead/follow: 86% lead, 14% follow
- Last fund: Likely still investing — raised $97M in 2022
Portfolio highlights
- Camino — Camino Leisure Holdings is a Spanish bar and restaurant that serves authentic food and wines.
- Arran Aromatics —
- Boost Juice Bars UK — Boost Juice Bars UK offer a range of smoothies and freshly squeezed juice products.
Oxford Science Enterprises is the university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companies taking on challenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Finland
Investor stats
- Total investments: 210
- Round size: Seed $1.3M–$12M; Series A $6.3M–$45M; Series B $9.1M–$168M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $299M in 2022
Portfolio highlights
- Salience Labs — Salience Labs is building a hybrid photonic-electronic chip for AI. We have designed a massively parallel, ultra-high-throughput Photonic Tensor Processing Unit. Photonics allows data to be modulated at up to 100 GHZ, and allows for high levels of parallelization using multiplexing. We integrate this photonic unit into a SoC architecture designedto exploit its high throughput for AI inference. Salience Labs technology is based on decades of research collaboration between Oxford University and the University of Münster, Germany.
- OMass Therapeutics — OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics against challenging disease targets.
- Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Denmark, United Kingdom
Investor stats
- Total investments: 409
- Round size: Series A $9.5M–$133M; Series B $15M–$135M; Series C $30M–$118M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $165M in 2018
Portfolio highlights
- IVERIC bio — IVERIC bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. The Company is currently developing both therapeutic product candidates for age-related retinal diseases and gene therapy product candidates for orphan inheritedretinal diseases.
- Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological diseases.
- SCHOTT Poonawalla — SCHOTT Poonawalla is a manufacturer of pharmaceutical containers, made of neutral glass tubing. The company provides parenteral packaging systems crafted from tubular glass, serving the pharmaceutical industry with a broad range of products including vials, pre-fillable syringes, ampoules, and cartridges.
Brilliant Ideas. Brilliant People. Brilliant Minds.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note
- Geography: United Kingdom, United States, Singapore
Investor stats
- Total investments: 289
- Round size: Seed $670k–$5.1M
- Lead/follow: 4% lead, 96% follow
- Last fund: Likely still investing — raised $23M in 2022
Portfolio highlights
- Unloq AI — Unloq is a Decision Intelligence Platform that turns your company data and live market signals into governed strategic recommendations. Approved, tracked, measured.
- Nourished — At Nourished we create innovative. personalised nutrition stacks that are truly unique to you. Vegan, waste-free and always made to order.
- K3 Metrology — K3 Metrology is a specialist metrology company commercialising laser‑based 3D coordinate measurement technology developed at the National Physical Laboratory. The company’s platform is designed to provide high‑accuracy, uncertainty‑aware dimensional data in large‑volume industrial environments, supporting inspection and assembly processes inadvanced manufacturing. Its systems integrate into production workflows where traceable measurements are required across complex geometries and large structures. The technology is applied in sectors such as aerospace, defence, and nuclear, where dimensional integrity and process control are critical.
Verticals:Enterprise, SaaS, Security, Networks, AI, VR/AR, Marketplace, Blockchain, Internet of Things, New materials, Electronics, Robotics, Cleantech, Agrotech, Seatech, Therapeutics, Digital Health, Diagnostics, Innovative Accommodation, Tourist Entertainment Companies, Tour Operators, Wine, Nautical and Equestrian Tourism, Theme Parks Mobile, Robotics Founded in 2012, Portugal Ventures is a venture capital firm based in Porto, Portugal. The firm is a part of the Banco Português de Fomento group. The firm seeks to invest in pre-seed, seed and series A stages
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: Portugal, United States, United Kingdom
Investor stats
- Total investments: 389
- Round size: Seed $121k–$1.9M; Pre-Seed $107k–$796k; Venture - Series Unknown $121k–$3.6M
- Lead/follow: 17% lead, 83% follow
- Last fund: May invest from a new fund soon — last raise in 2021
Portfolio highlights
- Aptoide — Find, discover and download the best apps and games for Android in the official Aptoide app store
- Unlockit — Unlockit will offer to public and governmental bodies the guarantee that everything within a real estate transaction is recorded, meaning better industry regulation, more taxes and public fees collected, and less overall fraud and money laundering activities.
- Outgoing — A ticketing tool that allows organizers to sell tickets directly on WhatsApp and Instagram. Users can purchase tickets through a personalized checkout process entirely within the chat, without registration or redirects. It also offers customer support that answers questions in real time.
Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.
Show more...Investment focus
- Industry: Software, Health Care, Manufacturing
- Stage:Seed, Debt Financing, Venture - Series Unknown
- Geography: United Kingdom, Australia, United States
Investor stats
- Total investments: 296
- Round size: Seed $279k–$3M; Debt Financing $19k–$3.7M; Venture - Series Unknown $383k–$5.5M
- Lead/follow: 61% lead, 39% follow
- Last fund: May invest from a new fund soon — raised $27M in 2018
Portfolio highlights
- Reacta Biotech — Reacta Biotech has been established to develop, manufacture and commercialise oral food challenge materials to pharmaceutical standards of Good Manufacturing Practice (GMP).
- MeOmics Technology — MeOmics Technology is a biotech company with a focus on improving the diagnosis and treatment of mental health illnesses. The company operates in the manufacturing industry and has a team of 9 employees. The team includes experts in Neuronal Cell Biology and Neuropsychopharmacology. The company's mission is to leverage technology to enhancethe understanding and treatment of mental health conditions.
- Outlook Expeditions — Outlook Expeditions provide overseas educational expeditions, adventure travel and service-learning projects for schools.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Speedinvest is a globally active European venture capital firm built on a simple belief: many move more. From six offices across EMEA, our sector-focused investment teams back relentless founders from pre–Seed to Growth with long-term conviction, providing day-one access to our global network of corporate customers, experts, industry leaders, and top-tier follow-on investors to scale smarter and faster. Building lasting companies like Bitpanda (Austria), Moove (Nigeria), Gigs (U.S.), Tide (UK), ARX Robotics (Germany), Wayflyer (Ireland), GoStudent (Austria), Seqera Labs (Spain), and Cylib (Germany) — together. Big ideas may start with one. But scaling and winning take The Power of More.
Show more...Investment focus
- Industry: Software, FinTech, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, Germany, Austria
Investor stats
- Total investments: 678
- Round size: Seed $797k–$7.9M; Pre-Seed $411k–$3.8M; Series A $4.5M–$32M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — raised $372M in 2022
Portfolio highlights
- Findery — Find and leave notes anywhere in the world, discover local knowledge, hidden secrets, and exciting stories. Share your travel knowledge, geoblog, or local news!
- GAMINSIDE — GAMINSIDE revolutionizes your relationship with your customers. As European full service provider, we deliver the complete package with solutions, services and software for gamified loyalty that is tailor-made and unique to your products, brands and customers. Integrate the best ideas from gamification and customer loyalty in your business areato exceed your commercial targets with GAMINSIDE.
- Polaron — Polaron connects process, structure, and performance using AI and image data to accelerate how materials are characterised, designed, and manufactured.
Seventure Partners is a French venture capital firm targeting in Tech/Digital and Life Sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion. Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with € 1 billion under management as of December 31, 2023. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations. Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors. The different funds/verticals on which Seventure Partners are focusing on today: - Life Sciences : Biotech, Healthcare, Nutrition - Tech/Digital : B2B SaaS, Fintech, Retailtech, Cybersecurity - Sports & Wellbeing - Blue Economy
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Series A, Series B, Seed
- Geography: France, United States, Germany
Investor stats
- Total investments: 275
- Round size: Seed $1.1M–$4.7M; Series A $3.2M–$28M; Series B $3.4M–$63M
- Lead/follow: 38% lead, 62% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Ekstere — Ekstere facilitates selling and purchasing verified-quality used bicycles at a reasonable price.
- Presto Engineering — We enable companies imagine and implement microelectronics solutions in high-value markets such as Industrial, Automotive, Communication and Medical.
- Kainova Therapeutics — Domain Therapeutics is a biopharmaceutical company focused on GPCR in immuno-oncology. Discover more than you think on our innovative cancer treatments tackling GPCR mediated-immunosuppression
Speak with our team, who can help you find sources of finance, engage with funders and secure investment to grow your business.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Venture - Series Unknown, Seed, Series A
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 291
- Round size: Seed $331k–$3.1M; Series A $1.7M–$7.5M; Venture - Series Unknown $199k–$4.1M
- Lead/follow: 13% lead, 87% follow
- Last fund: May invest from a new fund soon — last raise in 2015
Portfolio highlights
- Corvidae — Corvidae is a software company that provides data analysts, digital marketing, e commerce, and paid media solutions.
- IOTech — Discover IOTech Systems. Deploy, manage, and scale AI-driven, data-rich industrial systems at the edge with our open edge data platform.
- RoslinCT — We are the prefered global partner for cell and gene therapy solutions. With our wealth of expertise and infrastructure, we can support you at every step of your advanced therapy journey.
Northstar Ventures invests venture capital in early and later stage, high growth companies tackling global challenges, focusing on climate tech and healthy ageing.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: United Kingdom, United States, Indonesia
Investor stats
- Total investments: 280
- Round size: Seed $46k–$1.4M; Series A $295k–$10M; Venture - Series Unknown $261k–$3.8M
- Lead/follow: 25% lead, 75% follow
- Last fund: Likely still investing — raised $20M in 2024
Portfolio highlights
- OneClickComply — OneClickComply automates ISO 27001, SOC 2, Cyber Essentials and 240+ standards: evidence from 13,000+ tools, one-click fixes and an in-house audit team.
- Land Digital — Land Digital is a tech, web design, web creation, content marketing, digital marketing, SEO, and mobile application agency.
- Magnitude Biosciences — Magnitude Biosciences is a biotechnology firm combine experience in ageing research, the nematode C. elegans and automation.
Inveready is a leading Spanish financial services firm focused on investment solutions and wealth management.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Venture - Series Unknown, Debt Financing
- Geography: Spain, United States, France
Investor stats
- Total investments: 284
- Round size: Seed $400k–$4.7M; Debt Financing $1.2M–$6.5M; Venture - Series Unknown $594k–$5.7M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely still investing — raised $63M in 2024
Portfolio highlights
- Mirai RiskTech — AI-driven balance sheet management for banks: ALM and liquidity, FTP, and regulatory reporting on one data model.
- Blinker — Blinker specializes in the wholesale of hardware.
- Connecta Therapeutics — Connecta Therapeutics is a biotechnology company that develops new treatments for unresolved medical needs of the central nervous system. It focuses on the development of a first-in-class drug for the treatment of fragile X syndrome.
Deepbridge is a different kind of investment manager. They work closely with financial advisers and investors to design innovative products, ranging from investment in technology growth companies to asset-backed renewable energy projects. They also partner with innovative and committed management teams to help UK based companies realise theirpotential and become successful leading-edge businesses.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: United Kingdom, Spain, Australia
Investor stats
- Total investments: 91
- Round size: Seed $142k–$2.4M; Series A $2M–$15M; Venture - Series Unknown $259k–$2.8M
- Lead/follow: 69% lead, 31% follow
- Last fund: Likely still investing — raised $1.4M in 2022
Portfolio highlights
- upLYFT — upLYFT creates next-generation wearable technology that continuously analyses biomechanics and movement biomarkers, giving athletes, clinicians and physiotherapists precise insight into performance, recovery and injury risk.
- GeneralPractice.AI — GeneralPractice.AI - Infusing Artificial Intelligence into the Fabric of General Practice
- Spotlight Pathology — Spotlight Pathology develops decision support tools powered by artificial intelligence (AI) to help in the diagnosis of blood cancers.
Pre-Seed to Series A for Berlin-based founders. Where 30 years of expertise, capital and execution power meet.
Show more...Investment focus
- Industry: Software, Health Care, SaaS
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 268
- Round size: Seed $1M–$4.6M; Pre-Seed $468k–$2.6M; Series A $2.3M–$11M
- Lead/follow: 20% lead, 80% follow
- Last fund: Likely still investing — raised $120M in 2022
Portfolio highlights
- xHeron — xHeron uses artificial intelligence to automate guest service for short-term rental businesses.
- Nenna AI — Nenna AI is a powerful AI enablement platform designed for the secure application of AI technologies.
- Jurafuchs — Jurafuchs provides legal education via a mobile app.
Oxford Technology's SEIS fund and EIS fund enable private investors to access high growth technology startup opportunities and support UK innovation. SEIS and EIS tax reliefs offer downside protection, whilst gains can be tax free.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 112
- Round size: Seed $33k–$2.2M; Series A $786k–$8.5M
- Lead/follow: 8% lead, 92% follow
- Last fund: May invest from a new fund soon — last raise in 2012
Portfolio highlights
- OrganOx — OrganOx Limited was founded in 2008 to exploit normothermic preservation technology invented by Prof Peter Friend and colleagues and further developed by Prof Constantin Coussios at the University of Oxford.
- HydRegen — HydRegen is a biotechnology company that provides sustainable solutions for chemical manufacturing. HydRegen was founded in 2020 and was headquartered in Oxford, United Kingdom.
- Metacarpal — Metacarpal design upper-limb prosthetics without compromise. We aim to make the most robust, functional hand prosthesis that people love wearing because it works so effectively and looks so beautiful. Be proud to show your artificial side!
Idinvest Partners is a pan-European private equity manager focused on the low and middle-market segments. With over 6 billion euros under management, the company has developed several complementary areas of expertise, including equity investments in buyout deals focusing on both mid-size as well as young innovative European companies; primary investments in European private equity funds focusing primarily on the middle market segment; secondary investments; mezzanine investments in Europe; and private equity consulting. Idinvest Partners’ recent success stories include Criteo, Clear2Pay, Meetic, Prosensa, Converteam, Kwik Fit, Lastminute.com, Dailymotion, Deezer, Talend, Synthesio, Menlook, Vestiaire Collective, Pretty Simple, Curse.com, Withings, Kantox, Secret Escapes, Happn, Peakon, Dayuse, Botify, Financefox, Azalead and many more.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: France, United States, Germany
Investor stats
- Total investments: 351
- Round size: Series A $3.4M–$22M; Series B $7.8M–$66M; Venture - Series Unknown $4.1M–$37M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $97M in 2021
Portfolio highlights
- Actility — Actility provides IoT connectivity and solutions to power smart cities and industries.
- Pretty Simple — Video games studio based in Paris, France. Makers of Criminal Case and Sorcery School.
- StarTower — StarTower is a resource company built specifically for fully decentralized physical infrastructure and shared interaction. Based on the exclusive RIP encryption technology, StarTower realizes the interactive sharing of multiple resources with zero loss on mobile devices, thereby providing efficient resource transmission for terminal facilities. Itprovides more efficient, secure and reliable solutions in the fields of Internet of Things, smart cities, industrial automation, healthcare, etc.
Atlantic Labs supports and invests in mission-driven founders working on transformative technology ventures. <br><br>We partner with founders early, providing the capital, tools and network necessary to growing their companies and accompanying them on their entrepreneurial journey. We are currently active in areas including Digital Health, Future of Work, Machine Learning, Decentralized Networks, Mobility and Industrial Applications.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 275
- Round size: Seed $1.1M–$9.4M; Pre-Seed $850k–$3.5M; Series A $4.5M–$30M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely still investing — raised $110M in 2022
Portfolio highlights
- 42matters — 42matters offers a full suite of mobile and connected TV app intelligence solutions, including APIs, file dumps, and visual, web-based platforms.
- Phase0 — Payment platform for construction projects
- Lightspring — Lightspring is a photonics technology company developing advanced 3D optical interconnection solutions for photonic systems,Its platform enables precise, adaptable connections between chips, fibers, and light sources beyond traditional packaging constraints.This company focuses on scalable photonic integration to accelerate the development of high-performance optical systems.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: United Kingdom, United States, Hungary
Investor stats
- Total investments: 148
- Round size: Seed $250k–$2.1M; Series A $1.3M–$14M; Venture - Series Unknown $394k–$5.3M
- Lead/follow: 68% lead, 32% follow
- Last fund: May invest from a new fund soon — last raise in 2013
Portfolio highlights
- Ben — Ben is the all-in-one platform for any company to personalise benefits and reward.Our secret? Marrying a modern software (SaaS) platform with per-employee Mastercards and financial infrastructure. That’s how Ben instantly adds employee choice to your existing benefits, unlocks access to hundreds of additional options through Ben Card, all whilesaving you time and money.
- Distil.ai — Distil.ai is a software platform that helps businesses to understand their customers’ behavior and identify buying signals.
- MRC Engineering — MRC Engineering Providing a different option to the UK Rail Industry for Telecoms Design. Nationally renowned design specialists who provide extraordinary ...
AlbionVC backs Europe’s visionary founders solving the world’s hardest problems. We bring capital, know-how, and a shared ambition to win. With £1 billion in venture funds and convictionled investing across frontier technologies, our track record spans 100+ exits and early support for global champions such as Booking.com, Quantexa, Oviva, Elliptic and tem. From the first concept to global scale, we back founders bold enough to own the future.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series A, Seed, Series B
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 180
- Round size: Seed $2.4M–$12M; Series A $3.9M–$19M; Series B $10M–$45M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- Oshen — Oshen is a technology enterprise that creates miniature autonomous sailboats designed for persistent, wide-area ocean tracking.
- Outerlimit — Outerlimit is an AI security company focused on securing and governing agentic AI systems. Its platform provides visibility into AI agent activity, identity and access controls, risk assessment, and runtime security. The company helps organizations establish security and governance controls for AI agents operating across enterprise environments and manage their access to applications, data, and systems.
- Gravitee — Open Source API Management Platform - Gravitee
We turn exceptional individuals into funded founders. We back you first, then give you a bridge to Silicon Valley.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Machine Learning
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, Singapore, United States
Investor stats
- Total investments: 485
- Round size: Seed $54k–$6.7M; Pre-Seed $55k–$2.7M; Series A $5.1M–$41M
- Lead/follow: 24% lead, 76% follow
- Last fund: Likely actively investing — fresh fund, raised $133M in 2026
Portfolio highlights
- ByteAsk — Derisk your AI agents
- Sourcepulse — Your early warning system for software delivery (YC S23)
- Open Cosmos — Open Cosmos design, build and operate space missions, providing straightforward access to high quality satellite data and insights on a global scale.
We provide venture capital investment for the people, ideas and industries that will change the world. Learn about what we do and the kind of founders we back.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series A, Seed, Series B
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 442
- Round size: Seed $2.1M–$12M; Series A $3.4M–$22M; Series B $8M–$43M
- Lead/follow: 56% lead, 44% follow
- Last fund: May invest from a new fund soon — raised $108M in 2019
Portfolio highlights
- Grasp — Grasp is the world's first AI analyst for finance professionals. Our AI analyst automates company and market research for investment banks, private equity firms, and management consulting firms across the world.
- Living Optics — Living Optics is commercializing next generation imaging technology which leverages a compact camera system based on breakthroughs in hardware design and software processing.
- Monkey Bizness — Monkey Bizness is the largest provider of indoor family entertainment centres in the UK. Each centre includes a children's soft play area and is designed to provide a safe, clean and fun environment in which parents and children can feel comfortable. Monkey Bizness' centres provide a setting that encourages children to express themselvesthrough creativity and play as well as providing fresh and nutritious food to keep kids happy and healthy.Monkey Bizness currently has centres in eight locations: Lewes, Gosport, Poole, Sheffield, Stevenage, Hull Edinburgh and Glasgow.
Innovate UK is part of the UK Research and Innovation .
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Grant, Pre-Seed, Seed
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 1251
- Round size: Seed $143k–$3.5M; Grant $62k–$1.8M; Pre-Seed $58k–$1.3M
- Lead/follow: 76% lead, 24% follow
Portfolio highlights
- Neela Biotech — Transforming organic waste into carbon-negative sustainable aviation fuels through innovative biotechnology and AI.
- Stride Health Group — Digital health optimisation company, helping how people understand and optimise their health, fitness and longevity.
- Alchera Technologies — Alchera's AI-powered, cloud-based software platform provides real-time data on the movement of vehicles and pedestrians around cities and major infrastructure
Bayern Kapital (founded at the end of 1995) is a wholly owned subsidiary of the LfA Foerderbank Bayern (Bavaria‘s development bank). Bayern Kapital’s objective is to finance research and development as well as the market launch of new products, product diversifications, and expansion of the market share. The requesting company has to be located in Bavaria. Industries are e. g. IT/software, life sciences, new materials, micro-systems and environmental technologies. Bayern Kapital and its funds have invested in more than 250 companies and currently manages funds to the value of EUR 340 m. The five investing funds currently managed by Bayern Kapital are Seedfonds Bayern, Clusterfonds Start-Up!, Innovationsfonds, Innovationsfonds EFRE and Wachstumsfonds Bayern.
Show more...Investment focus
- Industry: Software, Health Care, SaaS
- Stage:Seed, Series A, Series B
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 263
- Round size: Seed $1.2M–$6.3M; Series A $3.9M–$32M; Series B $3.9M–$132M
- Lead/follow: 14% lead, 86% follow
- Last fund: May invest from a new fund soon — raised $29M in 2010
Portfolio highlights
- Hema.to — Flow cytometry analysis software, re-imagined. From raw FCS and LMD data to finalized report with AI-powered CellStudio.
- Arcos — Arcos is a civil safety and security technology company that builds and operates modern infrastructure protection and alarm management systems.
- HyImpulse Technologies — HyImpulse develops dedicated sub-orbital and orbital launch services using hybrid propulsion-based launch vehicles. Their SR75 is a single stage sounding rocket using a hybrid rocket engine to deliver institutional and commercial experiments into a micro gravity environment during a suborbital flight.
HAX is a program for Hard Tech startups taking their first steps towards commercialization. We provide hands-on support and investment as part of SOSV, a $1B AUM multi-stage venture firm.
Show more...Investment focus
- Industry: Robotics, Manufacturing, Health Care
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, Canada, China
Investor stats
- Total investments: 669
- Round size: Seed $100k–$4.7M; Pre-Seed $25k–$2.4M; Convertible Note $100k–$3.8M
- Lead/follow: 1% lead, 99% follow
Portfolio highlights
- 5QXT — 5QXT is a mining technology company that provides the design, development, and implementation of metal extraction processes.
- XFuel — XFuel is a fuel company that provides green and clean fuels to distributors and consumers. The company was founded in 2010 and is based in Palma de Mallorca, Baleares.
- Cortysis — Cortysis develops brain stimulation device for rapid spatial and temporal modulation of cortical networks
SyndicateRoom is fintech company made up of data-scientists, investment professionals, software developers and marketers with one mission: to be an early investor in every British startup success story. To do this – and make fund investors money – we don’t try to spot the next Big Thing. Instead, we apply a data-driven model to portfolio construction; a repeatable process designed to maximise returns and minimise risk for fund investors. As such, we build startup portfolios that don’t attempt to predict the future; they work to stack the odds in investors’ favour. Our fund, Access EIS, aims to build investors a diversified portfolio of 50+ companies by co‑investing exclusively with some of the UK’s best-performing angel investors.
Show more...Investment focus
- Industry: Health Care, Software, Medical
- Stage:Seed, Equity Crowdfunding, Pre-Seed
- Geography: United Kingdom, United States, India
Investor stats
- Total investments: 152
- Round size: Seed $390k–$2.7M; Pre-Seed $425k–$1.9M; Equity Crowdfunding $390k–$2.5M
- Lead/follow: 8% lead, 92% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- ManaMind — Human-like testing at machine scale. ManaMind delivers fully autonomous QA testing for video games - zero-shot, no code access, infinitely scalable.
- aflo — aflo automates inhaler techniques to improve the management of respiratory conditions.
- Joyvié — Joyvié Health designs medical continence products focused on managing severe faecal incontinence. The company is developing a patent-pending class of non-invasive faecal management briefs that prevent stool from contacting the skin. By separating waste from the body, the underwear aims to lower the risk of skin breakdown and secondary infectionwhile reducing the physical and emotional strain on caregivers. Joyvié Health works with care providers to pilot its products in real-world care environments and gather clinical and user feedback. Its offering is intended for adults with continence needs in institutional and home care settings, and for professionals responsible for continence care. The company also engages with investors and partners to advance product development and clinical evaluation.
CDP Venture Capital Sgr - National Innovation Fund aims to make venture capital a cornerstone of the country's economic development and innovation, creating the conditions for an overall and sustainable growth of the venture capital ecosystem.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Italy, United States, Switzerland
Investor stats
- Total investments: 302
- Round size: Seed $483k–$8.1M; Series A $3.3M–$23M; Venture - Series Unknown $652k–$17M
- Lead/follow: 41% lead, 59% follow
- Last fund: May invest from a new fund soon — raised $212M in 2021
Portfolio highlights
- Evja — Evja supports growers in optimizing the management and monitoring of irrigation, nutrition and protection of their crops through the use of OPI, the most advanced system for precision agriculture .
- TrueLayer — We power faster and safer online payments with our open banking payments network. Onboard users, accept payments & make payouts in seconds. Learn more today.
- Tretau — E-mobility is powered by its core - the electric motor. We at Tau are at the very core of the core: the copper winding wire, the magnetic core, the electrical steel.We just make it bet.
By Your Side from Day One
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 624
- Round size: Seed $658k–$8M; Pre-Seed $587k–$3.5M; Series A $5M–$30M
- Lead/follow: 18% lead, 82% follow
- Last fund: Likely actively investing — fresh fund, raised $220M in 2026
Portfolio highlights
- Rayon — Built for Speed. Designed for Teams.
- Metaview — Metaview uplevels the most outcome-defining part of your recruitment process: your interviews.
- Solvera AI — Solvera is an AI-native engineering firm on a mission to unleash the potential of every building engineer with AI. It develops advanced proprietary AI systems to help design better buildings, significantly faster, establishing a brand-new standard for MEP engineering.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and create value out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Australia
Investor stats
- Total investments: 235
- Round size: Seed $208k–$7.6M; Series A $2.4M–$30M; Series B $7.9M–$68M
- Lead/follow: 22% lead, 78% follow
- Last fund: Likely actively investing — fresh fund, raised $50M in 2026
Portfolio highlights
- Eight19 — Eight19, located in Cambridge, UK, develops and manufactures plastic photovoltaics for energy harvesting, for the internet of things and for off-grid applications. Through the innovative use of industry-standard, high-volume, roll-to-roll processes and solution-based organic photoactive materials, the company has a highly cost-effective route forscaling-up its technology to supply the largest markets. Eight19 is currently producing modules on a small scale for commercial partners with applications in indoor energy harvesting for wireless sensor and controllers, signage and display, and outdoor power for portable electronics. Our plastic PV modules benefit from flexibility, thinness, light-weight and robustness.
- Matter Machine — Matter Machine is an AI-driven materials discovery company that creates technologies that use materials chemistry, machine learning, and automated experimentation to speed up the discovery and optimization of next-generation materials.
- Mach42 — Machine Discovery is a University of Oxford spin-out commercializing new machine learning technology. We leverage proprietary neural network technology to accelerate expensive calculations — and we do it with minimal data and 99.9% fidelity.
Elaia is French venture capital firm focused on European digital and deep tech startups, from early stage to growth developpement. We back tech disruptors.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: France, United States, Spain
Investor stats
- Total investments: 241
- Round size: Seed $1.1M–$7.6M; Series A $2.7M–$23M; Series B $4.2M–$50M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely actively investing — fresh fund, raised $154M in 2026
Portfolio highlights
- Hema.to — Flow cytometry analysis software, re-imagined. From raw FCS and LMD data to finalized report with AI-powered CellStudio.
- RelaiSanté — RelaiSanté provides a digital coordination platform that connects hospitals with home care providers to manage patient return home. The company offers online tools for hospital teams, home help services, independent nurses and territorial health actors to organize care pathways after hospitalization. RelaiSanté enables secure information sharing, task assignment and monitoring of care arrangements between medical and social care stakeholders. Its products include dedicated interfaces for establishments, home care services and independent professionals. The platform supports teams in structuring discharge processes, reducing fragmentation of communication and clarifying responsibilities. RelaiSanté focuses on improving continuity of care between the healthcare facility and the patient’s home environment.
- Sim&Cure — Providing Physicians with advanced endovascular treatment solutions for a better Patient Care
Kima Ventures is one of the world's most active early-stage investors, investing in 2 to 3 startups per week all over the world; providing founders with funding, network, and support for them to reach the next steps of their journey. The firm invests from seed to Series A, mostly as lead investor but also working alongside other investors; backing ambitious founders who work hard to build awesome things that more and more people use everyday. The company helps them to build a great team, to learn very quickly, to keep the right focus and execute towards growth. Kima takes pride of itself in working side-by-side with entrepreneurs. They claim to understand that fundraising is only one step in the company’s journey, that’s why they take quick decisions and make the fundraising process as smooth as possible so the founders can get back to the work of building their business. Kima considers itself not only an investor, but a network of founders and experts sharing a pay it forward mindset. Headquartered in Paris with an office in London, the company was founded and backed by Xavier Niel, founder of Iliad and supporter of entrepreneurs through such projects as 42, Station F and 101projets. Over the last 5 years Kima has invested in over 400 startups in 24 different countries.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 771
- Round size: Seed $515k–$5.5M; Pre-Seed $591k–$3.8M; Series A $1.2M–$16M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Hoora — Hoora is a mobile gaming platform that offers an instant, scrollable feed of over 200 casual and arcade mini-games playable without downloads or waiting.
- Verso — Verso is an AI-powered qualitative market research platform that automates consumer insights at scale. It uses adaptive AI to conduct 1-on-1 video or voice interviews with consumers worldwide, turning open-ended conversations into structured, actionable insights in under a week.
- Netsec — Professional cybersecurity and managed IT services to protect your business 24/7.
Karista is an early-stage venture capital firm created in 2001 investing in Health, Digital, Tech, and NewSpace.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Series A, Series B
- Geography: France, United States, Finland
Investor stats
- Total investments: 162
- Round size: Seed $768k–$6.2M; Series A $1.4M–$23M; Series B $3M–$33M
- Lead/follow: 18% lead, 82% follow
- Last fund: Likely still investing — raised $44M in 2021
Portfolio highlights
- Kynogon — Autodesk game middleware products, including Beast, Navigation, HumanIK and Scaleform, will no longer be available for purchase.
- Advestigo — Advestigo S.A., a technology company, provides digital assets protection solutions. It offers theraography technology, which analyses digital content to generate content-based fingerprints; AdvestiCHECK, a software package that allows companies to monitor information technology networks and workstations; and AdvestiGUARD, a software package thatallows companies to monitor communication channels. The company was founded in 2002 and is based in Saint-Cloud, France. As of March 9, 2009, Advestigo S.A. operates as a subsidiary of Hologram Industries SA.
- Plasmabiotics — PENTAX Medical PlasmaBiotics: Ultra-fast endoscope reprocessing solutions to improve patient safety and infection prevention.
EISMEA is an executive agency of the European Commission that implements European Union programs supporting innovation, small and medium-sized enterprises, and the Single Market. The agency manages the European Innovation Council and European Innovation Ecosystems programs under Horizon Europe. It also implements the SME component of the Single Market Programme and the Interregional Innovation Investments instrument. EISMEA provides funding and support for innovators, researchers, businesses, regions, and other organizations through grants, procurement, investment, and advisory programs. Its activities cover innovation development, SME competitiveness, entrepreneurship, market access, consumer policy, standardization, and interregional innovation. The agency also supports the implementation of EU policies and programs related to innovation ecosystems and economic development.
Show more...Investment focus
- Industry: Manufacturing, Software, Biotechnology
- Stage:Grant, Venture - Series Unknown, Seed
- Geography: Spain, Italy, United Kingdom
Investor stats
- Total investments: 3546
- Round size: Seed $53k–$800k; Grant $54k–$2M; Venture - Series Unknown $573k–$2.6M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- AGADE — Esoscheletri Agade | Il primo esoscheletro intelligente per lavoratori progettato per ridurre il rischio di disturbi muscolari delle spalle nella movimentazione manuale dei carichi.
- BroadBit Batteries — BroadBit is a technology company developing revolutionary new batteries using novel sodium-based chemistries to power the future green economy.
- Aenitis Technologies — We develop innovative devices for cells therapy processing using Acoustic Radiation Forces.
ENISA is a public company under the Ministry of Industry, Energy and Tourism, through the Directorate General of Industry and Small and medium-sized enterprises which, since 1982, actively participates in the financing of viable and innovative business projects.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Debt Financing, Seed, Pre-Seed
- Geography: Spain, United States, France
Investor stats
- Total investments: 240
- Round size: Seed $79k–$1.6M; Pre-Seed $165k–$1.2M; Debt Financing $68k–$489k
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- Naturr — Nature, which seeks to connect small-scale artisanal food producers from rural areas with urban consumers. Nature platform could serve as an important bridge for promoting local and sustainable food systems, benefiting both rural producers and urban consumers i
- Pekata — Pekata offers technological solution that allows employee to customize hamper based on personal tastes, dietary restrictions.
- DARWIN Biomed — Biomedical Engineering
Noshaq offers financial services to help businesses develop.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed, Venture - Series Unknown
- Geography: Belgium, France, Germany
Investor stats
- Total investments: 82
- Round size: Seed $137k–$6M; Series A $3.6M–$16M; Venture - Series Unknown $2M–$16M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Le Fourgon — Le Fourgon provides contained drinks for home delivery. They offer milk, water, beer, wine, fruit juice, and sodas. They allow customers to have their drinks delivered free of charge during the day.
- Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
- Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
European Investment Bank operates as the lending institution of the European Union, offering loans, guarantees, and technical expertise to governments, businesses, and financial institutions. The organization focuses on areas such as climate action, digital transformation, housing development, and security-related initiatives. Its activities include funding large-scale infrastructure, supporting technology development, and facilitating access to capital for emerging and established enterprises. The bank also delivers advisory support to structure projects, improve investment readiness, and align initiatives with policy objectives.
Show more...Investment focus
- Industry: Energy, Biotechnology, Health Care
- Stage:Debt Financing, Post-IPO Debt, Venture - Series Unknown
- Geography: France, Germany, Italy
Investor stats
- Total investments: 600
- Round size: Post-IPO Debt $16M–$587M; Debt Financing $16M–$370M; Venture - Series Unknown $8.7M–$110M
- Lead/follow: 83% lead, 17% follow
Portfolio highlights
- RougeTx — RougeTx is a Netherlands-based biotech developing first-in-class small-molecule therapies for vascular diseases caused by pericyte dysfunction. Its lead candidate, RTX-001, targets hereditary haemorrhagic telangiectasia (HHT), an inherited disorder involving fragile blood vessels and recurrent bleeding.
- MedinCell — Join Medincell on a journey to transform global health with innovative therapies.
- Santander Brasil — Banco Santander in Brazil, its largest division in Latin America and one of the world's most important, accounting for 50%.
GO Capital is an independent management company and a major player in regional Seed and Venture Capital since 2003. With offices in Brittany, Pays de la Loire, Normandy, Centre-Val de Loire and the South of France, GO Capital contributes to the financing of responsible innovation in these regions. With a team of investors with complementarysectoral experience, we have a solid track-record in DeepTech. GO Capital has nearly 400 million euros under management, and mainly finances technology leaders in the digital and healthcare sectors and in the industry of the future.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: France, Canada, Israel
Investor stats
- Total investments: 141
- Round size: Seed $549k–$7.1M; Series A $2.1M–$13M; Venture - Series Unknown $974k–$9.5M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $25M in 2023
Portfolio highlights
- Axomove — Axomove specializes in the prescription of video-based physical exercises. The company's movement knowledge is used by health professionals to improve remote monitoring of their patients and to avoid Musculoskeletal Disorders (MSDs) at work.
- Olenbee — Olenbee develops fintech solutions that connect employee benefits directly to everyday card spending. The company offers a mobile application and employer platform that link meal vouchers, gift vouchers and other planned benefits to employees’ usual bank cards and accounts. Its title-restaurant product Olenfood allows food-related expenses to beidentified from card transactions and reimbursed in line with regulation. The Olengift service applies the same principle to gift vouchers without dedicated cards or closed merchant networks. Olenbee also works on additional benefit lines such as culture, sustainable mobility, sport, holidays and home office support. Its infrastructure is designed to handle eligibility rules and integrate with HR and payroll processes for employers, while providing dedicated spaces for merchants and employees.
- NeoXperiences — NeoXperiences develops technological solutions that bring audiences together around fun and interactive experiences.
Foresight Group is a listed infrastructure and private equity investment manager which has been managing funds on behalf of institutions and retail clients for more than 35 years. Foresight has over £7.2 billion of assets under management across a number of funds on behalf of some of the world’s largest institutional investors, family offices, private and high net-worth individuals and retail investors. Foresight's investment strategies are underpinned by a strong environmental, social & governance (“ESG”) focus, which increasingly meets the demands of today’s investors and ensures we are consistently working towards creating a sustainable legacy for future generations.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Venture - Series Unknown, Private Equity, Seed
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 232
- Round size: Seed $648k–$7.3M; Private Equity $2.1M–$8.3M; Venture - Series Unknown $979k–$6.5M
- Lead/follow: 64% lead, 36% follow
- Last fund: Likely actively investing — fresh fund, raised $120M in 2025
Portfolio highlights
- Vertal — Vertal is a food waste recycling company
- Bloemteknik — Bloemteknik develops, manufactures, and distributes high-quality modular lighting solutions for vertical farms and greenhouses. All solutions are cooperatively tailored with our growers to maximize production and reduce cost-of-ownership.
- Industrial Engineering Plastics — Industrial Engineering Plastics delivers specialist thermoplastic fabrication, DW154-compliant ductwork, machining, and plastics distribution
FAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Health Care VC Funds in Europe investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 48,091 VC funds investing in Europe Health Care startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!